Dr. Ari M. Vanderwalde, MD
- Medicare services, 2018
- 49
- Publications
- 50
- Clinical trials
- 4
- Industry payments
- $59,929
- State license
- 1
- Practice address
- 1265 Union Ave, Memphis, TN 38104
- Practice phone
- Call (901) 683-0055
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Vanderwalde's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ari M. Vanderwalde is a medical oncologist in Memphis, Tennessee
Dr. Vanderwalde practices in Memphis, Tennessee.
Dr. Vanderwalde's NPI, 1083801450, was assigned on October 1, 2007. Dr. Vanderwalde holds California license A97490.
- NPI
- 1083801450NPI Registry (opens in a new tab)
- NPI enumeration date
- October 1, 2007
- NPI status
- Active
- Practice phone
- (901) 683-0055
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Ari M. Vanderwalde's practice address is in Memphis, Tennessee
Dr. Vanderwalde's practice address in the NPI Registry is 1265 Union Ave, Memphis, TN 38104, in Shelby County. The practice phone is (901) 683-0055.
- NPI Registry address1265 Union Ave, Memphis, TN 38104 · Shelby CountyPhone(901) 683-0055
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Ari M. Vanderwalde's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vanderwalde practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Vanderwalde's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ari M. Vanderwalde is one of 99 medical oncologists in Tennessee
Medical oncology is Dr. Vanderwalde's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Vanderwalde is licensed in California.
Specialties and state licenses
- Medical oncology, CaliforniaPrimary
Medical oncologists near Dr. Vanderwalde
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ari M. Vanderwalde billed Medicare for 49 services in 2018
CMS data shows 49 Medicare services from Dr. Vanderwalde across 1 procedure code in 2018. Medicare paid $3,877 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Vanderwalde's Medicare services by type, 2017 to 2018
- 2017
- 2018
- Office and hospital visits
- 2017: 312018: 4958%
Dr. Vanderwalde compared with the Tennessee median for medical oncologists, 2018
- Dr. Vanderwalde
- Tennessee median
- Medicare services
- 49vs 1,19496% below
Medians across 94 medical oncologists in Tennessee with Dmand AI profiles that report each measure.
Dr. Vanderwalde's most billed Medicare procedure codes, 2018
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Vanderwalde?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vanderwalde and other medical oncologists in Tennessee.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ari M. Vanderwalde has 50 publications on record
Dmand AI links 50 papers to Dr. Vanderwalde, published from 2011 to 2025. 2025 was the busiest year, with 7. The most frequent topics are Biomarkers, Tumor, High-Throughput Nucleotide Sequencing and Lung Neoplasms. Dr. Vanderwalde has published most often in Clin Lung Cancer. Dr. Vanderwalde's most frequent co-authors are Balazs Halmos, MD, Jennifer Lorraine Gansert, MD and Wolfgang Michael Korn, MD.
Dr. Vanderwalde's papers by year, 2016 to 2025
Topics Dr. Vanderwalde writes about most
- Biomarkers, Tumor
- High-Throughput Nucleotide Sequencing
- Lung Neoplasms
- Melanoma
- Antineoplastic Agents
- Carcinoma, Non-Small-Cell Lung
- Breast Neoplasms
- Microsatellite Instability
Dr. Vanderwalde's most frequent co-authors
- Balazs Halmos, MD4 shared papers
- Jennifer Lorraine Gansert, MD3 shared papers
- Wolfgang Michael Korn, MD3 shared papers
Recent publications by Dr. Vanderwalde
Endocr Relat Cancer
See who Dr. Vanderwalde researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vanderwalde works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ari M. Vanderwalde has worked on 4 clinical trials
Dmand AI links Dr. Vanderwalde to 4 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Transitional Cell, Melanoma and Rectal Diseases. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Vanderwalde by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Vanderwalde's trials
- Carcinoma, Transitional Cell
- Melanoma
- Rectal Diseases
- Carcinoma, Renal Cell
- Colorectal Neoplasms
Investigators on the most trials with Dr. Vanderwalde
- Mark R. Albertini, MD2 shared trials
- Frances A. Collichio, MD2 shared trials
- Kenneth Frederick Grossmann, MD2 shared trials
Recent clinical trials with Dr. Vanderwalde
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies (opens in a new tab)
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (opens in a new tab)
S0820, Adenoma and Second Primary Prevention Trial (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Ari M. Vanderwalde received $59,929 in industry payments from 2016 to 2025
CMS Open Payments shows 110 general payments to Dr. Vanderwalde from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Bristol-Myers Squibb Company paid the most, $30,697. It also lists 10 research payments totaling $11,251 from 2021 to 2024.
General payments to Dr. Vanderwalde by program year, 2016 to 2025
General payments to Dr. Vanderwalde by kind, 2016 to 2025
- Consulting fees$43,19572%
- Travel and lodging$7,87413%
- Food and beverage$3,9417%
- Speaker and faculty fees$3,7666%
- Other$1,1542%
Companies that paid Dr. Vanderwalde the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Ari M. Vanderwalde's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ari M. Vanderwalde
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ari M. Vanderwalde's NPI number?
Dr. Ari M. Vanderwalde's NPI number is 1083801450. It was assigned on October 1, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Ari M. Vanderwalde?
Dr. Ari M. Vanderwalde is a medical oncologist in Memphis, Tennessee. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Ari M. Vanderwalde practice?
Dr. Vanderwalde practices at 1265 Union Ave, Memphis, TN 38104.
What is Dr. Ari M. Vanderwalde's office phone number?
The practice phone on file for Dr. Vanderwalde is (901) 683-0055.
What is Dr. Ari M. Vanderwalde's medical license number?
Dr. Vanderwalde holds California license A97490.
Does Dr. Ari M. Vanderwalde accept Medicare?
Yes. CMS data shows Dr. Vanderwalde billed Medicare for 49 services in 2018.
What services does Dr. Ari M. Vanderwalde bill to Medicare?
In 2018, Dr. Vanderwalde's most billed Medicare services were hospital inpatient care (99233).
Has Dr. Ari M. Vanderwalde received payments from drug or device companies?
CMS Open Payments shows $59,929 in general payments to Dr. Vanderwalde from 16 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Ari M. Vanderwalde been practicing?
Dr. Vanderwalde's NPI was assigned in 2007.
Does Dr. Ari M. Vanderwalde do research?
Dmand AI links 50 publications to Dr. Vanderwalde, published from 2011 to 2025. Dr. Vanderwalde has worked on 4 clinical trials.
Who does Dr. Ari M. Vanderwalde publish with?
Dr. Vanderwalde's most frequent co-authors are Balazs Halmos, MD (4 shared papers), Jennifer Lorraine Gansert, MD (3 shared papers) and Wolfgang Michael Korn, MD (3 shared papers).
Selling to medical oncology practices?
See medical oncologists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card